Qin Jian-Min, Wan Xing-Wang, Zeng Jin-Zhang, Wu Meng-Chao
Department of Hepatobiliary and Pancreatic Surgery, Beijing Chaoyang Hospital, Capital University of Medical Sciences, Beijing 100020, China.
Hepatobiliary Pancreat Dis Int. 2007 Jun;6(3):276-83.
Signal regulatory protein alpha1 (Sirpalpha1) is a member of Sirps families containing four immunoreceptor tyrosine-based inhibitory motifs (ITIMs) domains in the cytoplasm of and an activated substrate of receptor tyrosine kinase (RTK), that negatively regulates the RTK-dependent cell proliferating signal transduction pathway. Previously we found that Sirpalpha1 was closely associated with the occurrence and development of hepatocellular carcinoma (HCC) as well as liver regeneration. Since it is unclear about the regulatory mechanisms, we established the cell line transfected Sirpalpha1 gene and preliminarily clarified the mechanisms by which Sirpalpha1 negatively regulates the carcinogenesis and development of HCC.
Liver cancer Sk-Hep1 cell was respectively transfected with plasmids of pLXSN, pLXSN-Sirpalpha1 and pLXSN-Sirpalpha1delta4Y2, screened with the drug of G418 (1200 microg/ml), and various transfected Sk-Hep1 cell lines were obtained. The protein expressions of P65, P50, IkappaBalpha, cyclin D1 and Fas in various Sk-Hep1 cell lines were determined by Western blotting, and P65 and P50 were localized by the immunofluorescence technique.
Sirpalpha1 could significantly upregulate the protein expression of IkappaBalpha (vs. other cell lines, P<0.05) in the Sk-Hep1 cell, and downregulate the protein expressions of P65, P50 and cyclin D1 (vs. other cell lines, P<0.05) in the Sk-Hep1 cell. P65 protein expression was mainly localized in the cytoplasm in the pLXSN Sk-Hep1 cell, and in the nucleus of the Sk-Hep1 cell with mutant Sirpalpha1delta4Y2, but in nucleus of the Sk-Hep1 cell with wild Sirpalpha1. P50 protein expression was localized in the cytoplasm and nucleus of the pLXSN Sk-Hep1 cell, but in the nucleus of the Sk-Hep1 cell with wild Sirpalpha1 and mutant Sirpalpha1delta4Y2 plasmid.
Sirpalpha1 might negatively regulate and control the abnormal proliferation of liver cancer cells by influencing the protein content and localization of nuclear factor-kappa B, then influence the expression of cyclins such as cyclin D1 in the signal transduction pathway. It may be one of the important mechanisms by which Sirpalpha1 negatively regulates the carcinogenesis and development of HCC.
信号调节蛋白α1(Sirpα1)是Sirps家族成员,在细胞质中含有四个基于免疫受体酪氨酸的抑制基序(ITIM)结构域,是受体酪氨酸激酶(RTK)的活化底物,负向调节RTK依赖的细胞增殖信号转导通路。先前我们发现Sirpα1与肝细胞癌(HCC)的发生发展以及肝再生密切相关。由于其调控机制尚不清楚,我们建立了转染Sirpα1基因的细胞系,并初步阐明了Sirpα1负向调节HCC发生发展的机制。
分别用pLXSN、pLXSN-Sirpα1和pLXSN-Sirpα1δ4Y2质粒转染肝癌Sk-Hep1细胞,用G418(1200μg/ml)药物筛选,获得各种转染的Sk-Hep1细胞系。通过蛋白质免疫印迹法检测各种Sk-Hep1细胞系中P65、P50、IκBα、细胞周期蛋白D1和Fas的蛋白表达,并用免疫荧光技术对P65和P50进行定位。
Sirpα1可显著上调Sk-Hep1细胞中IκBα的蛋白表达(与其他细胞系相比,P<0.05),并下调Sk-Hep1细胞中P65、P50和细胞周期蛋白D1的蛋白表达(与其他细胞系相比,P<0.05)。P65蛋白表达在pLXSN Sk-Hep1细胞中主要定位于细胞质,在转染突变型Sirpα1δ4Y2的Sk-Hep1细胞中定位于细胞核,而在转染野生型Sirpα1的Sk-Hep1细胞中定位于细胞核。P50蛋白表达在pLXSN Sk-Hep1细胞的细胞质和细胞核中均有定位,但在转染野生型Sirpα1和突变型Sirpα1δ4Y2质粒的Sk-Hep1细胞中定位于细胞核。
Sirpα1可能通过影响核因子κB的蛋白含量和定位,进而影响信号转导通路中细胞周期蛋白如细胞周期蛋白D1的表达,负向调控肝癌细胞的异常增殖。这可能是Sirpα1负向调节HCC发生发展的重要机制之一。